精品人妻内射_欧美色色色色色色色色_韩日少妇_女人爽到高潮潮久久久_成人国产草莓视频在线观看 _成人国产无码_日韩成人无码\_色狠狠综合av熟女_久久无码视频在线观看_亚洲小说在线_人碰人人_国模冰莲自慰极品美胞_一级a一级a爱片免费_欧美日本二区_亚洲美女精品

北京索萊寶科技

專注于生物學試劑及試劑盒領域

服務熱線:18101056239

產品中心

PRODUCTS CENTER

當前位置:首頁產品中心抗體Polyclonal AntibodyK106415PAnti-FINC Polyclonal Antibody

Anti-FINC Polyclonal Antibody
產品簡介:

Anti-FINC Polyclonal Antibody
應用 WB
稀釋比例WB 1:3000.
交叉反應Mouse Rat

產品型號:K106415P

更新時間:2022-08-15

廠商性質:生產廠家

訪 問 量 :953

服務熱線

010-50973130

立即咨詢
產品介紹

Anti-FINC Polyclonal Antibody

英文名稱Anti-FINC Polyclonal Antibody
宿主Rabbit
別名Fn1;FN;Fibronectin;FNZ;GFND;GFND2
應用WB
稀釋比例WB 1:3000.
交叉反應Mouse Rat
蛋白分子量272kDa
Gene ID14286
保存Store at -20°C. Avoid freeze / thaw cycles.
儲存液Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法Affinity purification
亞型IgG
免疫原A synthetic peptide of human FINC
性狀液體
Public Immunogen RangeA synthetic peptide of human FINC
Subcellular LocationsExtracellular matrix
Swiss ProtP11276
克隆類型Polyclonal Antibody
背景資料Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts.Anastellin binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling.

在線留言

ONLINE MESSAGE

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
  • 服務熱線 010-50973130
  • 電子郵箱

    3193328036@qq.com

掃碼加微信

Copyright © 2025 北京索萊寶科技有限公司版權所有    備案號:

技術支持:化工儀器網    sitemap.xml

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |